STOCKSCREENR
Log In

ATRC

NASDAQ

AtriCure, Inc.

$29.58-0.86(-2.83%)Mkt Cap: $1.47B

Key Stats

Market Cap

$1.47B

P/E Ratio

-123.25

EPS

$-0.24

Dividend Yield

0.00%

52-Week Range

$28.29 — $43.18

Volume

919.99K

Avg Volume

625.43K

Beta

1.44

Valuation

P/E (TTM)

-123.25

Forward P/E

—

PEG Ratio

-2.02

P/S (TTM)

2.72

P/B (TTM)

2.84

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.02%

ROA (TTM)

-0.02%

ROIC

—

Gross Margin

0.75%

Operating Margin

-0.02%

Net Margin

—

Debt/Equity

0.18

Current Ratio

3.96

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.67%

EPS Growth (5Y)

-0.05%

Sales Growth (3Y)

+0.19%

Sales Growth (5Y)

+0.16%

EPS Est (This Year)

$-0.01

EPS Est (Next Year)

$0.27

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$3.49

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

0

Outstanding Shares

49.72M

Float

47.89M

Free Float %

96.32%

About

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

NASDAQ

IPO Date

2005-08-05

Employees

1300

CEO

Michael H. Carrel

Index Membership

—

Website

https://www.atricure.com

AtriCure, Inc. (ATRC) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $1.47B, a P/E ratio of -123.25, ATRC is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ATRC against other stocks using dozens of fundamental and technical filters.

Similar Stocks

MMSI

Merit Medical Systems, Inc.

$70.23

+1.53%

$4.17B

ICUI

ICU Medical, Inc.

$130.55

+2.83%

$3.22B

BLFS

BioLife Solutions, Inc.

$19.40

+1.68%

$937.02M

AZTA

Azenta, Inc.

$22.03

+5.36%

$1.01B

0I8F.L

DENTSPLY SIRONA Inc.

$12.23

+4.54%

$2.44B

0HQ1.L

Azenta, Inc.

$21.82

+0.88%

$999.73M

Frequently Asked Questions

What is AtriCure, Inc.'s P/E ratio?

AtriCure, Inc. (ATRC) has a trailing twelve-month (TTM) P/E ratio of -123.25. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does AtriCure, Inc. pay a dividend?

No, AtriCure, Inc. (ATRC) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is AtriCure, Inc.'s market cap?

AtriCure, Inc. (ATRC) has a market capitalization of $1.47 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.